Library / Laws / 115th Congress / House Bills / H.R. 5333
H.R. 5333
To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2018-03-19 | 79.1K | ⠃⠗⠋ |
| Reported in House | 2018-03-19 | 82.7K | ⠃⠗⠋ |
| Engrossed in House | — | 81.9K | ⠃⠗⠋ |
| Placed on Calendar (Senate) | — | 82.1K | ⠃⠗⠋ |